Tazanolast is primarily used as an antiallergic agent, particularly in the treatment of allergic conditions such as bronchial asthma and allergic rhinitis. It works by inhibiting the release of histamine and other inflammatory mediators from mast cells, thereby reducing allergic symptoms. The compound is often administered in the form of oral tablets or capsules, making it convenient for patients to use. Its effectiveness in managing chronic allergic conditions has made it a valuable option in therapeutic regimens aimed at improving quality of life for individuals suffering from persistent allergies. Additionally, Tazanolast is sometimes explored for its potential anti-inflammatory properties in other medical contexts, though its primary application remains focused on allergy management.